Banaag, Owen E.
HRN: 28-02-33 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/30/2026
OXACILLIN 500MG (VIAL)
05/30/2026
06/06/2026
IV
160mg
Q6
Staphylococcal SKin Infection
Checking Initial Appropriateness
05/30/2026
CEFTRIAXONE 1G (VIAL)
05/30/2026
06/06/2026
IV
310mg
Q12
PCAP
Checking Initial Appropriateness
05/30/2026
MUPIROCIN 2%, 15G (TUBE)
05/30/2026
06/06/2026
TOPICAL
On Affected Areas
BID
Staphylococcal SKin Infection
Checking Initial Appropriateness
05/30/2026
SILVER SULFADIAZINE 1%, 25G CREAM (TUBE)
05/30/2026
06/06/2026
TOPICAL
On Affected Areas
TID
Diaper Rash
Checking Initial Appropriateness